Abcam (LSE:ABC) Stock Based Compensation : £17.3 Mil (TTM As of Jun. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Abcam Stock Based Compensation?

Abcam's Stock Based Compensation for the six months ended in Jun. 2023 was £6.0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2023 was £17.3 Mil.

Abcam Stock Based Compensation Historical Data

The historical data trend for Abcam's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abcam Stock Based Compensation Chart

Abcam Annual Data

Trend

Jun12

Jun13

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Dec22

Stock Based Compensation

Get a 7-Day Free Trial

3.90

3.40

6.50

9.30

23.30

Abcam Semi-Annual Data
	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Jun22	Dec22	Jun23
Stock Based Compensation	Get a 7-Day Free Trial															7.30	-	12.00	11.30	6.00

Abcam Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £17.3 Mil.

Abcam Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Abcam's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.

Abcam (LSE:ABC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abcam PLC (LSE:ABC) » Definitions » Stock Based Compensation

Comparable Companies

Traded in Other Exchanges

N/A

Address

Discovery Drive, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AX

Website

https://www.abcam.com

Abcam PLC is a biotechnology company that develops and provides antibodies to life science research and clinical communities. The company's products allow research into the role of signaling and regulatory molecules and proteins in biological pathways. Such research ultimately leads to treatments for diseases such as cancer and immune deficiency disorders. Abcam's focused on broadening its product range, improving speed to market, and accessing underpenetrated consumer groups in its markets. The company also selectively pursues partnerships and acquisitions.

Abcam (LSE:ABC) Headlines

No Headlines